RBR-8g9897尚未招募未知
Evaluation of the efficacy and safety of new models of intraocular lenses for cataract surgery.
Associação Evangélica Beneficente de Minas Gerais0 个研究点开始时间: 2020年8月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 21Y 至 —（—）
入选标准
- •Patients who had a clinically documented diagnosis of age-related cataract (cortical, nuclear, sub-capsular, or a combination) who was considered amenable to treatment by
- •cataract extraction using the intracapsular facectomy method. Adult patients 21 years of age or older. Patients eligible for primary intraocular lens implantation. Patients willing and able to perform clinical and complementary tests for follow-up for a minimum period of 1 year after cataract surgery. Patients who require intraocular lens implantation powers ranging from 10 to 30 diopters. Patients with visual potential of 20/40 or better in the eye indicated for intraocular lens implantation. Patients with corneal cylinders to correct less than 1 diopter.
排除标准
- •Patients with the best corrected visual acuity less than or equal to 20/200 in the contralateral eye. Patients with any pathology of the anterior segment in which the procedure of intracapsular facectomy with primary IOL implantation is contraindicated (examples: keratoconus, corneal dystrophies or scars, anterior uveitis). Patients with corneal inflammation or edema, included and not limited to: keratitis, keratoconjunctivitis and keratouveitis. Patients with uncontrolled glaucoma or glaucoma under treatment. Patients with a history of retinal detachment. Patients with diabetic retinopathy (proliferative or non-proliferative). Patients with congenital, metabolic, traumatic or complicated cataracts. Patients with marked microphthalmia or aniridia. Patients who have had previous proposed eye surgery. Patients who have already received another IOL in the contralateral eye. Irregular corneal astigmatism. Amblyopia. Clinically significant changes in the retinal pigment epithelium / macula. Neovascularization of the iris, camerular and retinal angles. Severe recurrent inflammation of the anterior or posterior segment of unknown etiology. Optical atrophy. Patients with immunodeficiency (infectious, neoplastic or medicated). Patients on chronic use of systemic steroids or immunosuppressive drugs. Patients participating in another clinical trial simultaneously. Patients with strong dependence on intermediate vision, night vision or specific occupational requirements (examples: commercial pilots and professional drivers).
研究者
相似试验
已完成
不适用
To evaluate the efficacy and safety of the newly developed low-intensity ultrasound-transcutaneous nerve stimulation combined therapy for knee pain with osteoarthritis for 20 minutes, 3 times a day (more than 10 times a week) for a total of 8 weeks Single-institution, double-blind, randomized, parallel design, study-based clinical trialsKCT0003883Chonbuk National University Hospital40
已完成
2 期
Evaluation of the effectiveness of flavonoid lotion in the treatment of hemorrhoidsIRCT20210325050769N2Bagheiat-allah University of Medical Sciences100
尚未招募
Unknown
To know if the mouth wash prepared from certain herbal products is effective and safe to treat the gingivitisCTRI/2024/01/061413DR ZADC AMU ALIGARH
已完成
不适用
Evaluation of efficucy and safety of newly developed capsule endoscope and software.Small bowel diseaseJPRN-UMIN000010976Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University40
已完成
不适用
Investigation about safety and utility of the new minimally invasive needle .JPRN-UMIN000013005Yokohama City University Hospital4